Precigen (PGEN) Stock Sell: Should You Dump After CFO Sale?
A recent insider move at Precigen has many investors asking if a CFO’s share sale signals trouble. This deep-dive bre...
Biotech Stocks page aggregates 6 articles covering catalysts, earnings moves, and company updates to help you spot opportunities and manage biotech investments more confidently.
180 articlesA recent insider move at Precigen has many investors asking if a CFO’s share sale signals trouble. This deep-dive bre...
When a global pharma giant drops $1 billion on a single tech, investors sit up. This move by Johnson Johnson Just Pai...
In 2026, investors face a choice between a nimble biotech player and a global pharma titan. This guide compares Lexic...
A wall street analyst thinks Viking Therapeutics could unlock substantial upside if VK2735 delivers in Phase 3. Learn...
Moderna rose to fame with COVID-19 vaccines, but the road to sustained profits is more complex. This guide breaks dow...
When a biotech company’s leader sells shares, it can raise questions for investors. This guide breaks down how to int...
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
In May, Grail stock surged on optimism about FDA approval timing and potential reimbursement for the Galleri MCED tes...
Investors are buzzing about Revolution Medicines this year as its RAS-focused cancer programs advance. This article l...
When a high-level insider trims a stake, it can spark questions about a company’s near-term prospects. This article b...
When a biotech stock jumps after a conference, investors want to know if it’s sustainable. This article breaks down w...
Investors are watching Bionano Genomics as the company enters 2026 with evolving demand for optical genome mapping. T...